Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline in Cerebral Amyloid Angiopathy
NCT05680389Phase 2Unknown
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2020
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of minocycline in cerebral amyloid angiopathy (CAA), sponsored by Leiden University Medical Center. Status: unknown.
02
Drugs
minocycline
03
Conditions
cerebral amyloid angiopathy (CAA)
Beyond the preview
Go deeper on NCT05680389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05680389.